Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class II · Moderate risk

Proctofoam HC

cGMP deficiencies

Terminated cGMP deviation Mylan Pharmaceuticals Inc NDC 0037-6822-10 D-0452-2022
Class III · Low risk

Bortezomib

Failed stability specifications

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-865-60 D-0577-2022
Class III · Low risk

Azacitidine

Failed stability specifications

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-465-62 D-0576-2022
Class III · Low risk

Azacitidine

Failed stability specifications

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-305-62 D-0575-2022
Class II · Moderate risk

Tretinoin Capsules

Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

Terminated Dissolution failure Teva Pharmaceuticals USA NDC 0555-0808-02 D-0520-2022
Class I · High risk

Semglee (insulin glargine)

Labeling: Missing Label: label missing from some Semglee prefilled pens.

Terminated Labeling / mix-up Mylan Pharmaceuticals Inc NDC 49502-0196-71 D-0462-2022
Class III · Low risk

Leader

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 70000-0518-1 D-0386-2022
Class III · Low risk

CVS Health

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. D-0385-2022
Class III · Low risk

equate

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 49035-273-20 D-0383-2022
Class III · Low risk

Dr. Reddys

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. D-0382-2022
Class III · Low risk

Kroger

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 30142-611-14 D-0381-2022

Recalls by year